Sep 22 2026 Freshfields advised AbbVie on its multi-year collaboration with Iambic, a clinical-stage life sciences and technology company developing novel medicines through its AI-driven discovery and development platform, to accelerate the discovery and development of small molecule therapies with first-in-class and best-in-class potential across immunology, neuroscience, and oncology.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile